ArticleAnnals of surgical treatment and research2022

Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry.

Hannah Lois Kangleon-Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.